NovoCure Limited stock rating and score history
All changes in ratings, performance and outlook tracked over time.
NovoCure Limited stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does NovoCure Limited do? Business model and key facts
Get the full picture of NovoCure Limited: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Employees (FY): 1488
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Stocks related to NovoCure Limited
Selected based on industry alignment and relative market positioning.
Events and news impacting NovoCure Limited stock
Earnings, coporate decisions and industry developments that can affect the share price.
NovoCure Limited fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
